1. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser 1972;498:1–25.
2. Solensky R, Phillips EJ. Drug allergy. In: Burks AW, Holgate S, O'Hehir R, et al, eds. Middleton's allergy: principles and practice. 9th ed. Amsterdam: Elsevier, 2020:1261–1282.e1261.
3. Romano A, Atanaskovic-Markovic M, Barbaud A, et al. Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper. Allergy 2020;75:1300–1315.
4. Mayorga C, Fernandez TD, Montañez MI, Moreno E, Torres MJ. Recent developments and highlights in drug hypersensitivity. Allergy 2019;74:2368–2381.
5. Yang MS, Ban GY, Kim MH, et al. KAAACI Standardization Committee Report on the procedures and applications of the diagnostic tests for drug allergy. Allergy Asthma Respir Dis 2017;5:239–247.
6. Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168:555–562.
7. Phillips EJ, Bigliardi P, Bircher AJ, et al. Controversies in drug allergy: testing for delayed reactions. J Allergy Clin Immunol 2019;143:66–73.
8. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009;64:183–193.
9. Mayorga C, Celik G, Rouzaire P, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2016;71:1103–1134.
11. Broyles AD, Banerji A, Barmettler S, et al. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract 2020;8:S16–S116.
12. Staicu ML, Vyles D, Shenoy ES, et al. Penicillin allergy delabeling: a multidisciplinary opportunity. J Allergy Clin Immunol Pract 2020;8:2858–2868.e16.
13. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA 2019;321:188–199.
14. Vyles D, Antoon JW, Norton A, et al. Children with reported penicillin allergy: public health impact and safety of delabeling. Ann Allergy Asthma Immunol 2020;124:558–565.
15. Barlam TF, Cosgrove SE, Abbo LM, et al. Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:1197–1202.
17. Iammatteo M, Blumenthal KG, Saff R, Long AA, Banerji A. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review. J Allergy Clin Immunol Pract 2014;2:768–774.
19. Chopra N, Oppenheimer J, Derimanov GS, Fine PL. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol 2000;84:633–635.
20. Lee SH, Jo EJ, Mok JH, et al. Successful desensitization for vancomycin hypersensitivity. Allergy Asthma Respir Dis 2013;1:168–171.
21. Yoon D, Ahn H, Kim SY, Hwang SJ, Park HK, Kang HR. Successful rapid desensitization to trimethoprim-sulfamethoxazole-induced delayed hypersensitivity. Allergy Asthma Respir Dis 2015;3:155–158.
22. Ban GY, Jeong YJ, Lee SH, et al. Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications. Respir Med 2019;147:44–50.
23. Lee H, Kim MS, Yang HK, et al. Rapid desensitization to isoniazid and rifampin in an adolescent with active pulmonary tuberculosis. Allergy Asthma Respir Dis 2016;4:212–216.
24. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am 2009;29:585–606.